Alivus Life Sciences (NSE:ALIVUS) Common Stock: ₹245 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ALIVUS Alivus Life Sciences Ltd NSE:ALIVUS
86 GF Score
Price ₹1,168.40
GF Value ₹1,018.04
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Alivus Life Sciences Common Stock?

Alivus Life Sciences NSE:ALIVUS +0.62% 86 Common Stock is ₹245 Mil as of Mar. 2026. GuruFocus rates NSE:ALIVUS with a GF Score™ of 86/100 and a GF Value™ of ₹1,018.04 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Alivus Life Sciences's quarterly common stock declined from Sep. 2025 (₹245 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹245 Mil).

Alivus Life Sciences's annual common stock increased from Mar. 2024 (₹245 Mil) to Mar. 2025 (₹245 Mil) and increased from Mar. 2025 (₹245 Mil) to Mar. 2026 (₹245 Mil).

Alivus Life Sciences Common Stock Historical Data

* Premium members only.

The historical data trend for Alivus Life Sciences's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alivus Life Sciences Common Stock Chart

Alivus Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial 245.05 245.05 245.05 245.07 245.47

Alivus Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 245.07 0.00 245.36 0.00 245.47
NSE:ALIVUS
86GF Score
Alivus Life Sciences Ltd NSE:ALIVUS
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alivus Life Sciences Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹245 Mil mean?
Alivus Life Sciences (NSE:ALIVUS) has a Common Stock of ₹245 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Alivus Life Sciences and its competitors.
Is Alivus Life Sciences' Common Stock too high?
Alivus Life Sciences' current Common Stock is ₹245 Mil. Overall, Alivus Life Sciences has a GF Score™ of 86/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alivus Life Sciences' Common Stock compare to ZTS and UTHR?
Alivus Life Sciences' Common Stock of ₹245 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Drug Manufacturers company?
A good Common Stock depends on the Drug Manufacturers industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Alivus Life Sciences and its competitors. Alivus Life Sciences's current Common Stock is ₹245 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alivus Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Alivus Life Sciences (NSE:ALIVUS) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹1,018.04, compared to a current price of ₹1,168.40 — trading 14.8% above its estimated fair value. The current Common Stock is ₹245 Mil. Alivus Life Sciences' overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Alivus Life Sciences (NSE:ALIVUS), the current Common Stock is ₹245 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alivus Life Sciences (NSE:ALIVUS) Overvalued in 2026?

Based on GuruFocus' analysis, Alivus Life Sciences stock appears to be overvalued. The current stock price of ₹1,168.40 is trading 14.8% above its estimated GF Value™ of ₹1,018.04. GuruFocus considers Alivus Life Sciences to be Modestly Overvalued.

Key valuation signals for NSE:ALIVUS:

  • Common Stock: ₹245 Mil
  • GF Value™: ₹1,018.04 vs. price of ₹1,168.40 (14.8% above fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the NSE:ALIVUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alivus Life Sciences Business Description

Other Exchanges 543322:India
Address 470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099
Alivus Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disorders, pain management, diabetes, urology, gastrointestinal disorders, and other therapeutic areas.
86GF Score

Get the complete analysis for NSE:ALIVUS

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,168.40
Price
₹1,018.04
GF Value